Mori Masamichi | Drug Discovery Research, Astellas Pharma Inc., 21 Miyukigaoka, Tsukuba, Ibaraki 305-8585, Japan
スポンサーリンク
概要
- Mori Masamichiの詳細を見る
- 同名の論文著者
- Drug Discovery Research, Astellas Pharma Inc., 21 Miyukigaoka, Tsukuba, Ibaraki 305-8585, Japanの論文著者
関連著者
-
Mori Masamichi
Drug Discovery Research, Astellas Pharma Inc., 21 Miyukigaoka, Tsukuba, Ibaraki 305-8585, Japan
-
Hyodo Kazuyuki
Institute Of Material Structure Sciences High Energy Accelerator Research Organization
-
Yoneyama Akio
Advanced Research Laboratory Hitachi Ltd.
-
Hirai Yasuharu
Advanced Research Laboratory Hitachi Ltd.
-
Kudoh Masafumi
Drug Discovery Research Astellas Pharma Inc.
-
Takeda Tohoru
Graduate School Of Comprehensive Human Science Institute Of Clinical Medicine University Of Tsukuba
-
Takeda Tohoru
Graduate School of Comprehensive Human Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan
-
Amino Nobuaki
Drug Discovery Research, Astellas Pharma Inc., 21 Miyukigaoka, Tsukuba, Ibaraki 305-8585, Japan
-
Hyodo Kazuyuki
Institute of Materials Science, High Energy Accelerator Research Organization, 1-1 Oho, Tsukuba, Ibaraki 305-0801, Japan
-
Hirai Yasuharu
Advanced Research Laboratory, Hitachi Ltd., 2520 Akanuma, Hatoyama, Saitama 350-0395, Japan
-
Kudoh Masafumi
Drug Discovery Research, Astellas Pharma Inc., 21 Miyukigaoka, Tsukuba, Ibaraki 305-8585, Japan
-
Yamanaka Kentaro
Drug Discovery Research, Astellas Pharma Inc.
-
Kaneko Naoki
Drug Discovery Research, Astellas Pharma Inc.
-
Tabata Kenji
Drug Discovery Research, Astellas Pharma Inc.
-
Kita Aya
Drug Discovery Research, Astellas Pharma Inc.
-
Akabane Takafumi
Drug Discovery Research, Astellas Pharma Inc.
著作論文
- Non-invasive and Time-Resolved Observation of Tumors Implanted in Living Mice by Using Phase-Contrast X-ray Computed Tomography
- Synergistic antitumor activities of sepantronium bromide (YM155), a survivin suppressant, in combination with microtubule-targeting agents in triple-negative breast cancer cells